Highlights Nang Kuang Pharmaceutical Co., Ltd.

Equities

1752

TW0001752004

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
46.8 ^TWD	+1.96%		+2.97%	-12.20%

05-08	Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-26	Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	06/03/23	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/11/22	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/08/22	CI
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for Its ANDA	26/05/22	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	04/05/22	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	01/03/22	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	04/11/21	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended 31 March 2021	13/05/21	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	03/03/21	CI
Nang Kuang Pharmaceutical Co., Ltd. Receives U.S. Food and Drug Administration Tentative Approval for Abbreviated New Drug Application	27/01/21	CI
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for its ANDA	17/12/20	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	08/11/20	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	07/08/20	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	07/05/20	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	09/03/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Nang Kuang Pharmaceutical Co., Ltd.

Equities

1752

TW0001752004

Highlights

Filters